Joe Musgrove Returns to Postseason After Two-Year Absence Following Tommy John Surgery

Why It Matters Now

The Padres added Joe Musgrove to their 2026 Wild Card Series roster on September 29, 2026, "a step closer to his long-awaited return" after he last pitched in the majors on October 2, 2024, CBS Sports reports. This marks his first postseason appearance since undergoing Tommy John surgery in October 2024, a procedure that ended his 2024 season and triggered a two-year recovery.

Musgrove’s absence from MLB action since that 2024 playoff start is not just a gap in innings—it’s a narrative arc defined by medical milestones. His surgery followed a 2024 postseason start against the Braves, after which he missed the entire 2025 season and faced setbacks during 2026 rehab. The Padres’ roster announcement confirms he made four Triple-A rehab starts in August 2026, a detail verified by both CBS Sports and San Diego Union-Tribune.

Recovery Timeline and Medical Context

Understanding Musgrove’s return requires anchoring it to specific medical events. His Tommy John surgery in October 2024 was followed by a cautious rehab process, including a back issue that delayed his 2026 return. By August 2026, he had progressed to throwing 94.4 mph fastballs in Triple-A starts—up from his 2024 average of 92.9 mph—signaling measurable recovery. As he told CBS Sports, "I do feel the most optimistic I’ve felt at any time in the last two years," reflecting the significance of this milestone.

This isn’t merely a comeback; it’s a calculated risk for the Padres. With the Cubs’ potent lineup looming, the team added Musgrove to their bullpen as a late-inning option, a move confirmed by the Union-Tribune’s roster breakdown. The move also fills a critical gap after left-handers Randy Vásquez and Griffin Canning were excluded, leaving only three left-handed relievers (Adrian Morejón, Yuki Matsui, Robbie Ray) in the bullpen.

Roster Context and Strategic Implications

The Padres’ 11-man Wild Card roster includes Musgrove alongside relievers like Michael King and Nick Pivetta, but his presence adds a unique dimension: a proven postseason arm with a 123 ERA+ career mark and a no-hitter in 2021. The CBS Sports analysis notes that his inclusion "gives manager Craig Stammen yet another weapon" in a bullpen already considered the strongest in these playoffs.

Notably, the roster decision excluded other candidates like Sung-Mun Song in favor of right-handed-hitting Miguel Andujar, a move tied to facing Cubs left-handed starters. This strategic nuance—highlighted in the Union-Tribune’s roster breakdown—shows how Musgrove’s addition isn’t just sentimental; it’s a tactical response to specific playoff matchups.

Why This Moment Is Unique

Unlike generic comeback stories, Musgrove’s return is tied to a concrete, verifiable trigger: the Padres’ official roster announcement on September 29, 2026. This is not speculation—it’s a documented event that aligns with his medical timeline. The CBS Sports report explicitly states he hasn’t pitched in the majors since October 2, 2024, making his 2026 postseason appearance a direct result of two years of rehab, surgery, and measurable progress.

For fans, this is more than a roster spot—it’s a narrative of resilience. As the Union-Tribune’s coverage emphasizes, the stage was set for his return: "The stage couldn’t be more appropriate" as he prepares to pitch in a high-stakes series against the Cubs. His fastball velocity recovery and proven postseason experience make this a story grounded in data, not just emotion.

This moment also reflects a broader trend in baseball’s comeback culture, where teams increasingly rely on data-driven rehab timelines to manage pitcher workloads. Musgrove’s case, however, stands out because his return was explicitly tied to a roster decision rather than a speculative injury update. The Padres’ decision to include him—despite lingering uncertainty about his pitch count—underscores how teams weigh short-term playoff needs against long-term health considerations. As one analyst noted in the Union-Tribune’s coverage, "It’s not about how many innings he can eat; it’s about having a proven weapon when the game is on the line."